Skip to main content
S

StageZero Life Sciences Ltd. — Investor Relations & Filings

Ticker · SZLS.H ISIN · CA8525403017 LEI · 549300X4RIH613KZ1M68 TSX Human health and social work activities
Filings indexed 223 across all filing types
Latest filing 2020-06-23 Regulatory Filings
Country CA Canada
Listing TSX SZLS.H

About StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd. is a vertically integrated healthcare company dedicated to the development and commercialization of proprietary molecular diagnostic tests for early disease detection and management. The company specializes in blood-based diagnostics, often referred to as liquid biopsy, with a core mission to reduce the incidence of late-stage cancer through timely intervention. StageZero's offerings include the Aristotle multi-cancer panel test and associated health management services like AVRT. These services are often delivered through physician-led longevity clinics, integrating multiple health professionals with advanced diagnostic technology to provide comprehensive early detection strategies.

Recent filings

Filing Released Lang Actions
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2020-06-23 English
Final short form prospectus – English.pdf
Regulatory Filings
2020-06-23 English
Underwriting or agency agreement.pdf
Regulatory Filings
2020-06-23 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2020-06-23 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings
2020-06-23 English
Auditors' consent letter.pdf
Regulatory Filings
2020-06-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.